Tpg Gp A, LLC Amneal Pharmaceuticals, Inc. Transaction History
Tpg Gp A, LLC
- $3.27 Billion
- Q1 2025
A detailed history of Tpg Gp A, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tpg Gp A, LLC holds 12,328,767 shares of AMRX stock, worth $105 Million. This represents 3.16% of its overall portfolio holdings.
Number of Shares
12,328,767
Previous 12,328,767
-0.0%
Holding current value
$105 Million
Previous $97.6 Million
5.81%
% of portfolio
3.16%
Previous 2.69%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
246Shares Held
137MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA17.6MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$96.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$91.7 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$64 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.3MShares$45.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.29B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...